Medicines Australia’s Statement on the arrival of the Pfizer Vaccine
16 February 2021: Medicines Australia welcomes the arrival of the first doses of The Pfizer/BioNTech vaccine to Australia.
This marks a significant milestone in our nation’s vaccination program response to the pandemic and deliver much-needed vaccines to Australians.
We support the government in the prioritised roll-out to ensure those on the frontline and the most vulnerable receive priority access to the vaccine this includes quarantine and border workers, healthcare workers, aged care and disability care residents and staff.
The Pfizer/BioNTech vaccine is the first vaccine to receive provisional approval for use in Australia by the TGA. The Pfizer vaccines will be batch-assessed for quality, safety, and efficacy to ensure all Australians have confidence in the vaccines they receive.
Read more in the Prime Minister’s media release.
For further information, please contact Jasmine.Kaur@medicinesaustralia.com.au